Leigh J. Beglinger

University of Iowa — United States

Neuroscience · Life Sciences

42h-index6.3kcitations96works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic Neurodegenerative Diseases(50), Neurological disorders and treatments(30), Dementia and Cognitive Impairment Research(18), Mitochondrial Function and Pathology(15), Parkinson's Disease Mechanisms and Treatments(8)

Publications94 total

Cognitive changes associated with switching to frequent nocturnal hemodialysis or renal transplantation
BMC Nephrology·2016· 35 citedOpen Access
Practice Effects and Stability of Neuropsychological and UHDRS Tests Over Short Retest Intervals in Huntington Disease
Journal of Huntington s Disease·2015· 6 cited
Preliminary Study of the Association of White-Matter Metabolite Concentrations With Disease Severity in Patients With Huntington’s Disease
Journal of Neuropsychiatry·2014· 1 citedOpen Access
Does Interval Between Screening and Baseline Matter in HD Cognitive Clinical Trials?
Journal of Huntington s Disease·2014· 2 cited
Results of the citalopram to enhance cognition in Huntington disease trial
Movement Disorders·2013· 65 citedOpen Access
Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study
Journal of Psychiatric Research·2013· 62 citedOpen Access
Symptom Validity Test Performance in the Huntington Disease Clinic
Archives of Clinical Neuropsychology·2012· 17 citedOpen Access
Risk Factors for Delirium in Patients Undergoing Hematopoietic Stem Cell Transplantation
Annals of Clinical Psychiatry·2012· 18 citedOpen Access
Clinical predictors of driving status in Huntington's disease
Movement Disorders·2012· 28 citedOpen Access
Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions
Psycho-Oncology·2012· 55 citedOpen Access
Patterns of serotonergic antidepressant usage in prodromal Huntington disease
Psychiatry Research·2012· 25 citedOpen Access
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
Neurology·2012· 384 citedOpen Access
Substance abuse may be a risk factor for earlier onset of Huntington disease
Journal of Neurology·2012· 53 cited
Contributors
Elsevier eBooks·2012
Neuropsychology
Elsevier eBooks·2012
Estimating Premorbid IQ in the Prodromal Phase of a Neurodegenerative Disease
The Clinical Neuropsychologist·2011· 17 citedOpen Access
Perceived stress in prodromal Huntington disease
Psychology and Health·2011· 30 citedOpen Access
The RBANS Effort Index: Base Rates in Geriatric Samples
Applied Neuropsychology·2011· 35 cited
The Trail Making Test in prodromal Huntington disease: Contributions of disease progression to test performance
Journal of Clinical and Experimental Neuropsychology·2011· 58 citedOpen Access
Practice Effects Predict Cognitive Outcome in Amnestic Mild Cognitive Impairment
American Journal of Geriatric Psychiatry·2011· 121 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Jane S. Paulsen(35), Karen Duff(25), Douglas R. Langbehn(22), David J. Moser(14), Julie C. Stout(12), Kevin Duff(9), Elizabeth Aylward(8), Noelle E. Carlozzi(7), Susan K. Schultz(7), Martha Nance(6), Christopher A. Ross(6), Sarah Queller(6), Kevin Biglan(5), Michael R. Hayden(5), James A. Mills(5), Chiachi Wang(5), Peg Nopoulos(5), Jess G. Fiedorowicz(4), Hans J. Johnson(4), Elizabeth Penziner(4)